Obdulio Piloto

1.2k total citations
21 papers, 940 citations indexed

About

Obdulio Piloto is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Obdulio Piloto has authored 21 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 11 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Obdulio Piloto's work include Chronic Myeloid Leukemia Treatments (14 papers), Acute Myeloid Leukemia Research (10 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Obdulio Piloto is often cited by papers focused on Chronic Myeloid Leukemia Treatments (14 papers), Acute Myeloid Leukemia Research (10 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Obdulio Piloto collaborates with scholars based in United States, Singapore and Sweden. Obdulio Piloto's co-authors include Donald Small, Mark J. Levis, Patrick A. Brown, Michael L. Cleary, Tim C. P. Somervaille, Mark Murphy, Kevin S. Smith, Zhong Wang, Larry Witte and Rui Zheng and has published in prestigious journals such as Nature, Blood and Cancer Research.

In The Last Decade

Obdulio Piloto

21 papers receiving 910 citations

Peers

Countries citing papers authored by Obdulio Piloto

Since Specialization

Citations

This map shows the geographic impact of Obdulio Piloto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Obdulio Piloto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Obdulio Piloto more than expected).

Fields of papers citing papers by Obdulio Piloto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Obdulio Piloto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Obdulio Piloto. The network helps show where Obdulio Piloto may publish in the future.

Co-authorship network of co-authors of Obdulio Piloto

This figure shows the co-authorship network connecting the top 25 collaborators of Obdulio Piloto. A scholar is included among the top collaborators of Obdulio Piloto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Obdulio Piloto. Obdulio Piloto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A colorimetric chemical tongue detects and distinguishes between multiple analytes 2022 ·The Analyst ·Francis Lim, Tingjun Lei, (unknown), Nicole Lopez, (unknown), (unknown), Abhignyan Nagesetti, Andy Nelson, Kerstin Schmidt, Ta Chen Chang, Obdulio Piloto, Ian Cheong	1
2	Beta-Hemolytic Bacteria Selectively Trigger Liposome Lysis, Enabling Rapid and Accurate Pathogen Detection 2017 ·ACS Sensors ·(unknown), (unknown), Sahil K. Rastogi, Obdulio Piloto, Ian Cheong	18
3	A new distance measure for non-identical data with application to image classification 2016 ·Pattern Recognition ·(unknown), (unknown), Obdulio Piloto, Tobias Sjöblom, Ian Cheong	4
4	Next-Generation NAMPT Inhibitors Identified by Sequential High-Throughput Phenotypic Chemical and Functional Genomic Screens 2013 ·Chemistry & Biology ·Christina Matheny, Michael C. Wei, Michael C. Bassik, (unknown), Martin Kampmann, Masayuki Iwasaki, Obdulio Piloto, David E. Solow-Cordero, Donna M. Bouley, Rachel E. Rau, Patrick A. Brown, Michael T. McManus, Jonathan S. Weissman, Michael L. Cleary	57
5	Next-Generation NAMPT Inhibitors For ALL Identified By Sequential High-Throughput Phenotypic Chemical and Functional Genomic Screens 2013 ·Blood ·Michael C. Wei, Christina Matheny, Michael C. Bassik, (unknown), Martin Kampmann, Masayuki Iwasaki, Obdulio Piloto, David E. Solow-Cordero, Donna M. Bouley, Rachel E. Rau, Patrick A. Brown, Michael T. McManus, Jonathan S. Weissman, Michael L. Cleary	1
6	Further activation of FLT3 mutants by FLT3 ligand 2011 ·Oncogene ·Rui Zheng, (unknown), Bao Nguyen, Xiaochuan Yang, Obdulio Piloto, Mark J. Levis, Donald Small	42
7	Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy 2008 ·Nature ·Zhong Wang, Kevin S. Smith, Mark Murphy, Obdulio Piloto, Tim C. P. Somervaille, Michael L. Cleary	229
8	Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model 2008 ·Blood ·Li Li, Obdulio Piloto, (unknown), (unknown), Kogo Takamiya, Frederick Racke, David L. Huso, Donald Small	105
9	Constitutive Fms‐like tyrosine kinase 3 activation results in specific changes in gene expression in myeloid leukaemic cells 2007 ·British Journal of Haematology ·Kyu‐Tae Kim, Kristin Baird, Sean Davis, Obdulio Piloto, Mark J. Levis, Li Li, Peili Chen, Paul S. Meltzer, Donald Small	28
10	FLT3/ITD expression increases expansion, survival and entry into cell cycle of human haematopoietic stem/progenitor cells 2007 ·British Journal of Haematology ·Li Li, Obdulio Piloto, Kyu‐Tae Kim, Zhaohui Ye, (unknown), Xiaobing Yu, Mark J. Levis, Linzhao Cheng, Donald Small	31
11	FLT3 Ligand Is Required for Full Activation of FLT3 Mutants. 2006 ·Blood ·Rui Zheng, Obdulio Piloto, Donald Small	2
12	Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways 2006 ·Blood ·Obdulio Piloto, (unknown), Patrick A. Brown, (unknown), Mark J. Levis, Donald Small	143
13	Prolonged Exposure to FLT3 Inhibitors Leads to Resistance Via Activation of Parallel Signaling Pathways. 2006 ·Blood ·Obdulio Piloto, (unknown), Patrick Brown, (unknown), Mark J. Levis, Donald Small	3
14	IMC-EB10, an Anti-FLT3 Monoclonal Antibody, Prolongs Survival and Reduces Nonobese Diabetic/Severe Combined Immunodeficient Engraftment of Some Acute Lymphoblastic Leukemia Cell Lines and Primary Leukemic Samples 2006 ·Cancer Research ·Obdulio Piloto, Bao Nguyen, (unknown), (unknown), Yiwen Li, Larry Witte, Daniel J. Hicklin, Patrick A. Brown, Donald Small	28
15	Inhibitory Anti-FLT3 Antibodies Are Capable of Mediating Antibody-Dependent Cell-Mediated Cytotoxicity and Reducing Engraftment of Acute Myelogenous Leukemia Blasts in Nonobese Diabetic/Severe Combined Immunodeficient Mice 2005 ·Cancer Research ·Obdulio Piloto, Mark J. Levis, David L. Huso, Yiwen Li, Hongli Li, (unknown), Rajiv Bassi, Paul Balderes, Dale L. Ludwig, Larry Witte, Zhenping Zhu, Daniel J. Hicklin, Donald Small	42
16	The Anti-FLT3 Monoclonal Antibody EB10 Is Cytotoxic to FLT3 Inhibitor Resistant Cells In Vivo. 2005 ·Blood ·Obdulio Piloto, (unknown), Bao Nguyen, Li Li, Yiwen Li, Larry Witte, Daniel J. Hicklin, Donald Small	2
17	EB10, an Anti-FLT3 Monoclonal Antibody, Selectively Targets ALL Cell Lines and Primary ALL Blasts without Interfering with Normal Hematopoiesis. 2004 ·Blood ·Obdulio Piloto, Patrick A. Brown, Li Li, Bao Nguyen, (unknown), (unknown), Yiwen Li, Hongli Li, (unknown), Larry Witte, Daniel J. Hicklin, Donald Small	1
18	FLT3-Targeted Therapy Selectively Kills MLL-Rearranged Infant and Childhood ALL Blasts In Vitro and in Vivo. 2004 ·Blood ·Patrick A. Brown, Obdulio Piloto, Mark J. Levis, Sheila Shurtleff, Dario Campana, James R. Downing, Donald Small	2
19	Suppression of leukemia expressing wild-type or ITD-mutant FLT3 receptor by a fully human anti-FLT3 neutralizing antibody 2004 ·Blood ·Yiwen Li, Hongli Li, (unknown), Dan Lu, Rajiv Bassi, Yan Wu, Haifan Zhang, Paul Balderes, Dale L. Ludwig, Bronislaw Pytowski, Paul Kussie, Obdulio Piloto, Donald Small, Peter Böhlen, Larry Witte, Zhenping Zhu, Daniel J. Hicklin	42
20	FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells 2003 ·Blood ·Rui Zheng, Mark J. Levis, Obdulio Piloto, Patrick A. Brown, Brenda R. Baldwin, Norbert Claude Gorin, Miloslav Beran, Zhenping Zhu, Dale L. Ludwig, Dan Hicklin, Larry Witte, Yiwen Li, Donald Small	155

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact